Cited by 376Bone health and osteoporosis researchBone Metabolism and DiseasesBone health and treatments

Bone Turnover Markers in the Diagnosis and Monitoring of Metabolic Bone Disease

Open access
Greenblatt, Matthew B, Tsai, Joy N, Wein, Marc N·2017·Clinical Chemistry

Abstract

BACKGROUND: Disorders of bone metabolism, most notably osteoporosis, are highly prevalent and predispose to fractures, causing high patient morbidity and mortality. Diagnosis and monitoring of bone metabolic defects can present a major challenge as these disorders are largely asymptomatic and radiographic measures of bone mass respond slowly to changes in bone physiology. CONTENT: Bone turnover markers (BTMs) are a series of protein or protein derivative biomarkers released during bone remodeling by osteoblasts or osteoclasts. BTMs can offer prognostic information on fracture risk that supplements radiographic measures of bone mass, but testing using BTMs has to take into account the large number of preanalytic factors and comorbid clinical conditions influencing BTM levels. BTMs respond rapidly to changes in bone physiology, therefore, they have utility in determining patient response to and compliance with therapies for osteoporosis. SUMMARY: BTMs are a useful adjunct for the diagnosis and therapeutic monitoring of bone metabolic disorders, but their use has to be tempered by the known limitations in their clinical utility and preanalytic variables complicating interpretation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1373/clinchem.2016.259085

Cites

97 of 97 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The most often measured resorption markers in clinical practice for diagnosis of osteoporosis are ICTP, β-CTX, and NTX.

    “The most often measured resorption markers in clinical practice for the diagnosis of osteoporosis are the C-terminal telopeptide of type I collagen (ICTP), β-CrossLaps (β-CTX), and the N-terminal telopeptide of type I collagen (NTX) [56].”

    From Osteoporosis: Molecular Pathology, Diagnostics, and Therapeutics (2023) · cites this paper as [56]

    The C- and N-Terminal Telopeptides section describes CTX and NTX as resorption markers used in clinical practice and identifies CrossLaps assays for CTX. But it says ICTP has limited clinical application and may respond more to skeletal metastases than to postmenopausal osteoporosis. The cited paper therefore does not support listing ICTP among the most often measured markers for osteoporosis diagnosis. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Degradation markers pyridinoline (Pir) and deoxypyridinoline (Dpir) are proxy measurements for osteoclast activity.

    “Degradation markers, such as pyridinoline (Pir) and deoxypyridinoline (Dpir), are proxy measurements for osteoclast activity.”

    From Osteoporosis: Molecular Pathology, Diagnostics, and Therapeutics (2023) · cites this paper as [56]

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Greenblatt, M. B., Tsai, J. N., & Wein, M. N.
Affiliations
  • Weill Cornell Medicine (US)
  • Massachusetts General Hospital (US)
Corresponding author
Greenblatt, Matthew B
Venue
Clinical Chemistry
Published
2017-02-01
Volume
63
Issue
2
Pages
464-474
ISSN
  • 0009-9147 (ISSN-L)
  • 1530-8561
OpenAlex
W2560774896
Cited by
376
References
97
Citations by year
2026: 24 · 2025: 50 · 2024: 54 · 2023: 60 · 2022: 54 · 2021: 49 · 2020: 39 · 2019: 23 · 2018: 16 · 2017: 6 · 2014: 1
FWCI
2.39
Type
journal article
Language
en
Open access
Locations
  • Clinical Chemistry (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Career Award for Medical Scientists from the Burroughs Wellcome Fund
  • Office of the Director of the NIH (DP5OD021351)
  • Junior Investigator Award from the Musculoskeletal Transplant Foundation
  • NIAMS of the NIH (K23AR068447, K08AR067285)
Topics
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
  • Health Sciences › Medicine › Oncology › Bone health and treatments
Keywords
bone turnover markers, metabolic bone disease, osteoporosis, fracture risk, bone remodeling, osteoblasts, osteoclasts, pre-analytical variables, treatment monitoring, biomarkers
MeSH terms
Bone and Bones, Bone Diseases, Metabolic, Humans, Biomarkers, Bone Remodeling

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review